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Abstract
Vector-borne diseases (VBDs) cause significant morbidity and mortality each year in the United 
States. Over the last 14 yr, over 700,000 cases of diseases carried by ticks, mosquitoes, and fleas 
have been reported from U.S. states and territories to the Centers for Disease Control and 
Prevention. The number of reported cases has been increasing annually with two major trends: a 
steady increase in tick-borne diseases and increasing intermittent outbreaks of mosquito-borne 
arboviruses. The factors that are driving VBD introduction and emergence vary among diseases 
but are not likely to disappear, indicating that current trends will continue and probably worsen in 
the absence of effective prevention and control tools and implementation capacity. There are a 
number of challenges to preventing VBDs, including the lack of vaccines and effective vector 
control tools, insecticide resistance, and eroding technical capacities in public health entomology 
at federal, state, and local levels. For these reasons, a national strategy is needed to address VBD 
threats and to reverse the alarming trend in morbidity and mortality associated with these diseases.
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Vector-borne diseases (VBDs) are of great importance in the United States, resulting in 
significant morbidity and mortality each year. From 2004 to 2017, over 700,000 cases of 16 
diseases caused by viral, bacterial, or parasitic agents were reported to the Centers for 
Disease Control and Prevention (CDC) (Centers for Disease Control and Prevention 2018, 
Curren et al. 2018, Rosenberg et al. 2018). In 2017, the top five reported VBDs were Lyme 
disease (42,743 cases), anaplasmosis/ehrlichiosis (7,718 cases), spotted fever rickettsiosis 
(7,718 cases), babesiosis (2,368 cases), and West Nile virus (WNV) disease (2,097 cases). 
Among the reported WNV disease cases, there were 146 deaths.
In terms of the total burden of illness associated with VBDs each year, it is important to note 
that reported cases represent only a small fraction of those sickened by these infections. The 
reasons for under-reporting vary by disease. For WNV infection, most reported cases have 
neuroinvasive disease (meningitis, encephalitis, and acute flaccid paralysis) as these patients 
are often hospitalized and tested. However, for every one case of WNV neuroinvasive 
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disease, 30–70 WNV non-neuroinvasive cases occur (Burakoff et al. 2018). Yet only a tiny 
fraction of those are reported, in large part due to under-diagnosis. Many patients do not 
seek medical care, physicians may not consider WNV as a possible diagnosis, and 
diagnostic tests may not be ordered. For Lyme disease, under-reporting is not influenced so 
much by under-diagnosis as by the burden associated with the reporting process itself, which 
can require both laboratory and supportive clinical data for case classification. Recent 
studies indicate that the total number of annual cases likely exceeds 300,000 (Hinckley et al. 
2014, Nelson et al. 2015), suggesting that national under-reporting for Lyme disease occurs 
by a factor of around 8- and 12-fold.
VBD Trends
VBD cases in the United States have steadily increased over the last two decades. From 
2004 to 2016, the number of reported VBD cases tripled (Rosenberg et al. 2018). Two 
primary trends characterize the observed increase in reported cases. The first is a steady 
increase in tick-borne disease incidence over a broadening geographic distribution (Figs. 1 
and 2). For Lyme disease, from 1993 to 2012, the number of high-incidence counties more 
than tripled in the northeastern United States and more than doubled in the north-central 
United States (Kugeler et al. 2015). Nearly all other tick-borne disease cases have also 
increased as well, as evidenced by record numbers of cases for all reportable tick-borne 
diseases in 2017 (Centers for Disease Control and Prevention 2018). Ixodes scapularis Say 
(Acari: Ixodidae), the most important tick vector in the United States, can transmit the 
pathogens that cause borreliosis, anaplasmosis, babesiosis, and Powassan virus disease. The 
number of counties where I. scapularis is established has more than doubled in the last 20 yr 
(Eisen et al. 2016).
A second observed trend accounting for the increase in VBDs in the United States over the 
last two decades is increasing intermittent outbreaks of mosquito-borne arboviruses. These 
include WNV, which has become endemic throughout the contiguous United States during 
this time, as well as exotic diseases like chikungunya and Zika, which have been more 
recently introduced to the western hemisphere. In the U.S. territories, dengue is a constant 
threat, resulting in widespread periodic outbreaks. Large outbreaks of dengue, chikungunya, 
and Zika in the Caribbean region have led to introductions into the continental United States 
with subsequent local mosquito-borne transmission (Brathwaite Dick et al. 2012, Kendrick 
et al. 2014, Likos et al. 2016). Most recently, during 2016 and 2017, there were 42,798 
symptomatic cases of Zika reported in U.S. states and territories, including 37,032 locally 
acquired cases in Puerto Rico and 5,334 travel-related and 231 locally acquired cases, 
presumably mosquito-transmitted cases, in the continental United States (Centers for 
Disease Control and Prevention 2019a).
Drivers for VBD Emergence
The factors contributing to VBD introduction and emergence in the United States are 
complex and vary among diseases. Global travel and trade have been responsible for 
introduction of exotic arboviruses going all the way back to the slave trade in the 1600s 
when both yellow fever virus and its mosquito vector Aedes aegypti (L.) (Diptera: 
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Culicidae) were presumably introduced from Africa (Barrett and Monath 2003). Shipments 
of used tires and lucky bamboo have transported Aedes albopictus (Skuse) (Diptera: 
Culicidae) throughout the Americas (Madon et al. 2002). Both Zika and chikungunya were 
introduced into the United States via infected travelers (Kendrick et al. 2014, Likos et al. 
2016). Most recently, the Asian Longhorned tick Haemaphysalis longicornis Neumann 
(Acari: Ixodidae) has been documented as an invasive species now reported from nine states 
and detected biting a range of animals, including livestock, wildlife, pets, and humans 
(Beard et al. 2018). This tick is an important disease vector in other parts of the world and 
was presumably introduced into the United States through movement of pets or livestock.
Quite different factors have likely contributed to the emergence of arboviral and 
‘arbobacterial’ diseases associated with I. scapularis and some of the other native tick 
species in the United States. The geographic expansion of Lyme disease and accompanying 
increase in human infection has been associated with changing land use patterns, chiefly 
with reforestation, expanding deer populations, changes in biodiversity, and growth of 
suburbia (Wood and Lafferty 2013). This combination of factors has placed an ever-
increasing human population at greater risk for exposure to the bites of infected ticks. 
Climate change has no doubt influenced both the geographic distribution and seasonality of 
tick-borne diseases (Beard 2016). Temperature minimums define the northern distribution of 
arthropod vectors and influence their basic reproductive rate and subsequent population size 
(Ogden et al. 2006, Ogden et al. 2014). Milder winters, earlier springs, warmer summers, 
and longer growing seasons have been linked to changes in disease seasonality with Lyme 
disease (Moore et al. 2014, Monaghan et al. 2015, Beard et al. 2016).
Travel, trade, changing land-use patterns, growth of suburbia, and climate change are factors 
that are increasing at accelerating rates. Consequently, the effect of these factors as drivers 
for VBD emergence are likely to increase, strongly suggesting that in the absence of 
effective prevention and control tools and the capacity to implement them in a timely 
manner, the trends and patterns observed over the last two decades will continue and likely 
worsen.
Challenges to Preventing and Controlling VBDs
Several factors hinder prevention and control of VBDs. Currently, no licensed vaccines exist 
for any endemic human VBD in the United States. As a result, VBD prevention relies on 
vector control efforts and personal protection. Yet there is a dearth of high-quality data 
demonstrating the efficacy of vector control on reducing disease occurrence during seasonal 
exposure or outbreaks. For example, a randomized control trial involving over 2,700 homes, 
looking at a single springtime barrier acaricide application achieved 63% reduction in ticks 
between treated and untreated properties. There was no reduction, however, in the number of 
human tick encounters or physician-diagnosed Lyme disease cases (Hinckley et al. 2016). 
There is a similar lack of robust data from randomized control trials that demonstrate the 
efficacy of available interventions for control of mosquito-borne diseases (Wilson et al. 
2015). High-quality data from rigorously designed studies that capture both entomologic and 
epidemiologic outcomes are badly needed for making sound, evidence-based public health 
recommendations. Large prospective community trials that are adequately powered to 
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measure a reduction in disease incidence are very expensive, which is the reason why most 
data on the efficacy of vector control for prevention of VBDs come from observational 
studies.
Another hindrance to effective vector control is insecticide resistance. This was particularly 
important in Puerto Rico during the Zika outbreak where populations of Ae. aegypti from 
San Juan were resistant to multiple insecticides, including both Type I and Type II 
pyrethroids (Estep et al. 2017). Insecticide resistance varies by target species and can be 
highly localized. However, relatively little systematically collected information is available 
to guide effective vector control in the United States. A recent survey that evaluated 1,083 
vector control organizations found that 84% failed to maintain at least one of the five core 
competencies for effective vector control (National Association of County and City Health 
Officials 2017). These competencies included such things as conducting routine mosquito 
surveillance and pesticide resistance monitoring and then using the resulting data to guide 
operational decisions. Maintaining high-quality information on vector population density 
and susceptibility to available pesticides is critical for effective vector control.
Still other challenges exist to VBD prevention and control activities such as public 
opposition to the use of synthetic pesticides. In Miami, Florida, there was significant public 
protest to aerial spraying of the insecticide Naled during the Zika virus outbreak in 2016, 
despite the occurrence of active local virus transmission (Karimi and Visser 2016). In Puerto 
Rico, during the same outbreak, public outcry resulted in a decision not to allow aerial 
spraying at all despite over 35,000 locally acquired Zika cases. The lack of a timely response 
can also compromise the effectiveness of vector control interventions. During the 2012 
WNV outbreak in Texas, there were 1,868 reported cases including 844 cases of WNV 
neuroinvasive disease and 89 deaths (Centers for Disease Control and Prevention 2019b). 
Following a mild winter and early spring, the first positive mosquito pool was detected in the 
Dallas-Fort Worth area in late May close to when the first human case was reported (Chung 
et al. 2013). The number of cases rose precipitously from mid-June through early August. 
Aerial spraying was not implemented, however, until mid-August, after human case numbers 
were already declining. These data suggest that early vector-control interventions based on 
vector surveillance data are not always implemented effectively.
For tick control, the challenges are quite different. Interventions are seldom carried out by 
municipal governments or vector control districts but more frequently implemented by 
private property owners, chiefly homeowners. The deer that host adult I. scapularis and the 
rodents that harbor the various pathogens transmitted by this tick range freely between 
homeowner properties and adjacent green spaces, depositing ticks that can infect residents. 
Identifying interventions that are effective and affordable for homeowners has been a 
significant challenge for tick-borne disease prevention and control (Eisen and Eisen 2018). 
In the absence of a vaccine for any of these pathogens, safe and effective tick control 
methods must be developed and validated for use in local communities in order to reverse 
the upward trends in tick-borne disease incidence.
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The Need for a National Strategy
The increasing disease incidence and other challenges noted above, together with eroding 
technical capacities in public health entomology at federal, state, and local levels (Hadler et 
al. 2014), leave the nation largely unprepared to respond to VBD threats. A recent call to 
action was issued to create a national strategy for addressing this need (Petersen et al. 2019). 
Both development and implementation of such a strategy will require collaboration between 
stakeholders at multiple governmental levels, together with partners from academics, 
industry, patient organizations, and communities. An effective national strategy should 1) 
develop a vision, mission, goals, and substrategies within the goals, and 2) describe 
accountability among the federal agencies and institutes. Once a national strategy has been 
created, detailed action plans can be developed and prioritized, which can be used to define 
key activities and specify success measures and timelines. Some of the specific needs that 
should be addressed and sustained in a national strategy to respond to VBD emerging threats 
include 1) basic understanding of VBD biology, ecology, and exposure risk, 2) vector and 
pathogen detection and diagnosis, 3) disease prevention and control tools and methods, 4) 
facilitated process to bring new vector control products to market and deploy them when 
needed, and 5) adequate workforce and resource capacity.
The complex nature of VBD transmission cycles, typically involving zoonotic reservoirs and 
vector populations, both of which are broadly dispersed in the environment, pose unique 
technological challenges for effective control. Consequently, successful efforts to establish 
and maintain an effective national system to detect and respond to emerging VBD threats 
will require a high level of coordination, cooperation, and perseverance involving all of the 
key stakeholders.
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Figure 1. 
Total Tick-Borne Disease Cases, United States, 2004–2017. Total number of reported cases 
of tick-borne diseases each year from 2004 through 2017.
Beard et al. Page 8
J Med Entomol. Author manuscript; available in PMC 2020 March 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Reported cases of Lyme disease in the United States. One dot placed randomly within 
county of residence for each confirmed case. Note: In 2016, Massachusetts transitioned to a 
surveillance method that relies primarily on laboratory reports. This method does not 
currently align with the national surveillance case definition as set by the Council of State 
and Territorial Epidemiologists. Therefore, information on most Lyme disease cases 
occurring in Massachusetts is not sent to CDC. Contact the MA Department of Public 
Health for case numbers. While Lyme disease cases are reported in the western United 
States, they are not shown on this map because there was not significant change to note over 
the time period shown.
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